Veterinary Medicines

VALERAMOL 200 MG/G ORAL POWDER FOR PIGS

Authorised
  • Paracetamol
Download as PDF

Product identification

Medicine name:
VALERAMOL 200 MG/G ORAL POWDER FOR PIGS
Valeramol, 200 mg/g suukaudne pulber sigadele
Active substance:
  • Paracetamol
Target species:
  • Pig
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Paracetamol
    200.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Oral powder
Withdrawal period by route of administration:
  • Oral use
    • Pig
      • Meat and offal
        1
        day
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN02BE01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Estonia
Package description:
  • Bottle of 150 g
  • 1 kg in a bag
  • 6 kg in a bag
  • Cardboard box containing 10 x 150 g

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application - change in active substance(s) (Article 19(1)(a) of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • Pharmanovo Veterinaerarzneimittel GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Animed Service AG
Responsible authority:
  • State Agency Of Medicines
Authorisation number:
  • 1133123
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0459/001
Concerned member states:
  • Austria
  • Estonia
  • Germany
  • Hungary
  • Latvia
  • Lithuania
  • Poland

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 16/01/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."